- Home
- SWKS vs BMRN Comparison
SWKS vs BMRN Comparison
Compare SWKS & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWKS
- BMRN
- Stock Information
- Founded
- SWKS 1962
- BMRN 1996
- Country
- SWKS United States
- BMRN United States
- Employees
- SWKS N/A
- BMRN N/A
- Industry
- SWKS Semiconductors
- BMRN Biotechnology: Pharmaceutical Preparations
- Sector
- SWKS Technology
- BMRN Health Care
- Exchange
- SWKS Nasdaq
- BMRN Nasdaq
- Market Cap
- SWKS 10.2B
- BMRN 11.3B
- IPO Year
- SWKS 1968
- BMRN 1999
- Fundamental
- Price
- SWKS $74.94
- BMRN $58.27
- Analyst Decision
- SWKS Hold
- BMRN Buy
- Analyst Count
- SWKS 18
- BMRN 23
- Target Price
- SWKS $72.69
- BMRN $93.14
- AVG Volume (30 Days)
- SWKS 2.6M
- BMRN 2.4M
- Earning Date
- SWKS 08-05-2025
- BMRN 10-28-2025
- Dividend Yield
- SWKS 3.74%
- BMRN N/A
- EPS Growth
- SWKS N/A
- BMRN 154.69
- EPS
- SWKS 2.50
- BMRN 3.40
- Revenue
- SWKS $4,011,700,000.00
- BMRN $3,063,608,000.00
- Revenue This Year
- SWKS N/A
- BMRN $13.32
- Revenue Next Year
- SWKS N/A
- BMRN $9.37
- P/E Ratio
- SWKS $29.94
- BMRN $17.14
- Revenue Growth
- SWKS N/A
- BMRN 18.36
- 52 Week Low
- SWKS $47.93
- BMRN $52.93
- 52 Week High
- SWKS $110.76
- BMRN $93.04
- Technical
- Relative Strength Index (RSI)
- SWKS 54.93
- BMRN 50.79
- Support Level
- SWKS $73.86
- BMRN $57.15
- Resistance Level
- SWKS $76.53
- BMRN $58.80
- Average True Range (ATR)
- SWKS 1.76
- BMRN 1.28
- MACD
- SWKS 0.22
- BMRN -0.01
- Stochastic Oscillator
- SWKS 59.10
- BMRN 68.94
About SWKS Skyworks Solutions Inc.
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments aimed at addressing complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria (PKU), hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development.